Erhad Ascic

This inventor holds 5 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: H. Lundbeck A/s. Active years: 2022-2026.

USPTO Granted Patents = 5 (Patent Applications = 4)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

5 out of 511

H. Lundbeck A/s

patents

Years Active: 2022-2026

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12590106 - Spiromacrocyclic orexin 2 receptor agonists (2026-03-31),

2. 12398106 - Catecholamine carbamate prodrugs for use in the treatment of parkinson's disease (2025-08-26),

3. 12391650 - Catecholamine prodrugs for use in the treatment of Parkinson's disease (2025-08-19),

4. 11466027 - Modulators of the NMDA receptor (2022-10-11),

5. 11358971 - Prodrugs of modulators of the NMDA receptor (2022-06-14),

Title: Erhad Ascic - Innovative Inventor from Valby

Introduction: Erhad Ascic is a talented inventor hailing from Valby, Denmark, known for his groundbreaking contributions to various fields.

Latest Patents: Erhad Ascic holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced manufacturing processes.

Career Highlights: Throughout his career, Erhad Ascic has worked tirelessly to develop cutting-edge solutions that have the potential to revolutionize industries and improve the quality of life for many.

Collaborations: Erhad Ascic has collaborated with leading research institutions, universities, and companies to bring his innovative ideas to life and make a positive impact on society.

Conclusion: Erhad Ascic's passion for innovation and his dedication to creating a better future through his inventions make him a truly inspiring figure in the world of technology and beyond.

This text is generated by artificial intelligence and may not be accurate.